At present, FDA does not disclose the identity of companies involved in outbreaks without an associated recall because it considers a company name to be “confidential commercial information." Stop Foodborne Illness argues this practice is not legally consistent.
In this episode of Food Safety Matters, we speak to food regulatory legal expert Kathleen Sanzo, J.D. about the implications of FDA’s voluntary approach to phasing out synthetic food dyes from the U.S. food supply and how food companies can prepare.
EFSA established a provisional safe intake level for adults for CBD as a novel food while highlighting that data gaps continue to exist regarding possible effects of CBD on the liver and the endocrine, nervous, and reproductive systems.
This article examines shifting USDA regulatory expectations, evolving risk assessment tools, and realistic strategies to manage Salmonella as a true public health risk rather than solely a process control issue.
Food Standards Australia New Zealand (FSANZ) has published the findings of a national survey of antimicrobial resistance (AMR) in foodborne bacteria on raw beef, chicken, and pork meat at retail.
CalRecycle has issued a final draft of the Plastic Pollution Prevention and Packaging Producer Responsibility Act (SB 54), which establishes an extended producer responsibility (EPR) program to manage packaging and single-use plastic. Western Growers shared concerns about the produce industry’s ability to qualify for categorical exclusion.
As part of its efforts to encourage industry to phase out the use of petroleum-based synthetic food dyes, FDA is expanding the allowed uses of the label claim “no artificial colors” on food products and has approved a new naturally derived colorant for food.
In the wake of a high-profile safety incidents involving powdered infant formula, FAO/WHO have issued a call for experts and data to support JEMRA in conducting a risk assessment that will help the Codex Committee on Food Hygiene update the Codex Alimentarius standards for powdered formula.
New Jersey Governor Phil Murphy has signed into law the Protecting Against Forever Chemicals Act, which prohibits statewide the manufacture and sale of certain consumer goods that contain intentionally added per- and polyfluoroalkyl substances (PFAS).
Following the ByHeart botulism outbreak, FDA intends to begin testing infant formula products and ingredients for Clostridium botulinum to help determine whether contamination by the pathogen is a “foreseeable hazard that companies could test for.”